Original Research
Accepted on 27 May 2025
Efficacy of Pembrolizumab with or without Lenvatinib in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in Patients Following Transjugular Intrahepatic Portosystemic Shunt
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers